重大事件
即時報告
8-K
2026-07-28
QT Imaging股東會通過全部議案 增股權激勵額度及委任核數師
AI 繁中摘要
QT Imaging Holdings（納斯達克：QTI）昨日（7月28日）舉行2026年度股東大會，會上所有議案均獲股東投票通過，公司已計劃同日向美國證交會提交8-K表格，正式公佈點票結果。
會議通過的重點議案包括：一）選出Zeev Weiner教授及Bryan Timm為第二類董事，任期至2029年股東週年大會；二）委任BPM LLP為截至2026年12月31日止財政年度的獨立註冊會計師事務所；三）修訂公司2024年股權激勵計劃，增加可供授出的股份授權及儲備數目。
QT Imaging是一家專注以低頻聲波技術進行無輻射乳腺影像檢查的醫療設備公司，今次增加股權激勵計劃額度，相信有助公司保留及吸引人才，配合其商業化進程。對投資者而言，董事會換班及核數師委任屬例行程序，料不會對公司日常營運構成重大影響；惟增加股份授權或會帶來輕微攤薄效應，值得持續留意。
展開英文正文
EX-99.1 2 a2026x07x28ex991pressrelea.htm EX-99.1 Document Exhibit 99.1 QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting Novato, Calif. – July 28, 2026 - QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (NASDAQ: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today that at the Annual Meeting of Company’s stockholders (the “Annual Meeting”) held on July 28, 2026, the Company’s stockholders voted to approve (i) the election of Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the Company’s 2029 Annual Meeting of Stockholders or until their respective successors are elected and qualified, (ii) the appointment of BPM LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 and (iii) an amendment to the Company’s 2024 Equity Incentive Plan to increase the number of shares authorized and reserved for issuance. The Company plans to file the results of the Annual Meeting, as tabulated by an independent inspector of elections, on Form 8-K with the Securities and Exchange Commission today. About QT Imaging Holdings, Inc. QT imaging is a public medical device company engaged in the research, development, and commercialization of innovative imaging systems that use low-frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the Company’s website at www.qtimaging.com and follow us on LinkedIn. View source version on businesswire.com: https://www.businesswire.com/news/home/20260728706279/en/ For media inquiries, please contact: InvestorsCORE IRTirth [email protected] MediaCORE IRMatthew [email protected]